A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.

University of Alabama at Birmingham School of Medicine, Department of Medicine, Birmingham, Alabama, United States

City of Hope, Duarte, California, United States

David Geffen School of Medicine at UCLA, Los Angeles, California, United States

UC Davis Medical Center, Sacramento, California, United States

Rush University Medical Center, Division of Infectious Diseases, Chicago, Illinois, United States

University of Kentucky Medical Center, Division of Infectious Diseases, Lexington, Kentucky, United States

Johns Hopkins Hospital, Baltimore, Maryland, United States

University of Michigan Health System (UMHS) - A. Alfred Taubman Health Care Center, Ann Arbor, Michigan, United States

Karmanos Cancer Institute - Detroit, Detroit, Michigan, United States

University of Minnesota, M Health Fairview Medical Center, Minneapolis, Minnesota, United States

Washington University School of Medicine, Infectious Diseases Clinical Research Unit, St Louis, Missouri, United States

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Duke University Medical Center, Duke Infectious Diseases, Durham, North Carolina, United States

The University of Texas Health Science Center at Houston, Department of Internal Medicine, Houston, Texas, United States

UT MD Anderson Cancer Center, Houston, Texas, United States

Monash Medical Center Clayton, Clayton, Australia

The Alfred Hospital, Melbourne, Australia

Peter MacCallum Cancer Center, Melbourne, Australia

Royal Melbourne Hospital, Parkville, Australia

Princess Alexandra Hospital, Woolloongabba, Australia

Kepler University Hospital GmbH, Department of Internal Medicine IV - Pulmonology, Linz, Austria

Medical University Vienna, Department of Internal Medicine I, Clinical Department of Infections and Tropical Medicine, Vienna, Austria

Charleroi Grand Hospital (GHDC) - Les Viviers Site, Charleroi, Belgium

University Hospitals Leuven, Campus Gasthuisberg, Department of Hematology, Leuven, Belgium

UCL Mont-Godinne University Hospitals, Yvoir, Belgium

University of Alberta, Edmonton, Alberta, Canada

Juravinski Hospital - Hamilton Health Sciences, Hamilton, Ontario, Canada

Vancouver Coastal Health Research Institute (VCHRI), Vancouver, Canada

Nantes University Hospital Center - Hotel Dieu Hospital, Department of Infectious and Tropical Diseases, Nantes, France

University Medical Center of Johannes Gutenberg University Mainz, Mainz, Rhineland-Palatinate, Germany

Rambam Health Care Campus, Institute of Infectious Diseases, Haifa, Israel

Chaim Sheba Medical Center, Department of Infectious Diseases, Ramat Gan, Israel

The Tel Aviv Sourasky Medical Center, Infectious Diseases Unit, Tel Aviv, Israel

Shamir Medical Center, Department of Infectious Diseases, Ẕerifin, Israel

Maggiore Polyclinic Hospital, Foundation IRCCS Ca' Granda, Milan, Italy

University Polyclinic Hospital of Modena, Modena, Italy

Polyclinic San Matteo, IRCCS, Pavia, Italy

University Hospital of Pisa, Pisa, Italy

Giuliano Isontina University Health Authority, Trieste, Italy

Radboud University Medical Center (Radboudumc), Department of Intensive Care, Nijmegen, Netherlands

Erasmus Medical Center, Deoartment of Infectious Diseases, Rotterdam, Netherlands

University Hospital Virgen Macarena, Seville, Andalusia, Spain

Hospital del Mar, Department of Infectious Diseases, Barcelona, Catalonia, Spain

Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain

University Hospital Cruces, Barakaldo, Spain

Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

University Hospital Ramon y Cajal, Department of Infectious Diseases, Madrid, Spain

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan

Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand

Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand

Songklanagarind Hospital, Hat Yai, Thailand

Srinagarind Hospital, Khon Kaen, Thailand